SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-010816
Filing Date
2020-07-29
Accepted
2020-07-29 16:05:52
Documents
5
Period of Report
2020-07-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arcutis-8xk72920.htm 8-K 41886
2 EX-10.1 arcutisexhibit101-8xk.htm EX-10.1 49089
3 EX-10.2 arcutisexhibit102-8xk.htm EX-10.2 79459
4 footer11.jpg GRAPHIC 56488
5 image011.jpg GRAPHIC 74374
  Complete submission text file 0001628280-20-010816.txt   352120
Mailing Address 2945 TOWNSGATE ROAD SUITE 110 WESTLAKE VILLAGE CA 91361
Business Address 2945 TOWNSGATE ROAD SUITE 110 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39186 | Film No.: 201057379
SIC: 2834 Pharmaceutical Preparations